Cognito Therapeutics, a neurotechnology company birthed out of MIT, is pioneering breakthrough technology that may be able to slow the progression of Alzheimer’s disease.
Skin is our first line of defense, protecting us from damage and keeping out unwanted visitors. As we age, it weakens. Research may have found a workaround.